Researcher profile
Zheng-Xiong Xi
Affiliations
Organizations
Public evidence
9 connected articles
Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.2026 · Europe PMCCannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice.2026 · Europe PMCNeuronal versus Glial CB2 Receptors: Insights from a Novel CB2-KO-eGFP Reporter Mouse Line2025 · PubMed Central Open AccessGPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice.2024 · Europe PMCAM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects.2024 · Europe PMCPPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.2023 · PubMed Central Open AccessNeutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.2022 · Europe PMCPossible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.2020 · Europe PMCCB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ<sup>9</sup>-Tetrahydrocannabinol (Δ<sup>9</sup>-THC)-Induced Aversive Effects in Mice.2017 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.